Data regarding the cardiac toxicity of cabozantinib lacks. The aim of our study was to assess the risk of cabozantinib-related cardiotoxicity in mRCC patients.
Iacovelli, R., Ciccarese, C., Fornarini, G., Massari, F., Bimbatti, D., Mosillo, C., et al. (2019). Cabozantinib-related cardiotoxicity: a prospective analysis in a "real world" cohort of metastatic renal cell carcinoma patients. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 85(6), 1283-1289 [10.1111/bcp.13895].
Cabozantinib-related cardiotoxicity: a prospective analysis in a "real world" cohort of metastatic renal cell carcinoma patients
Massari, Francesco;Di Nunno, Vincenzo;Ardizzoni, Andrea;
2019
Abstract
Data regarding the cardiac toxicity of cabozantinib lacks. The aim of our study was to assess the risk of cabozantinib-related cardiotoxicity in mRCC patients.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
